Augmented reality gives surgeons x-ray vision in real time

Cambridge Consultants, a product design and development firm, has introduced an augmented reality (AR) surgical system capable of giving surgeons “x-ray vision” in real time. This system aims to improve patient outcomes and reduce surgical risk.

Using the Microsoft HoloLens headset, Cambridge Consultants developed the system to allow surgeons to see the inside of a patient while they are operating through minimally invasive openings.

“AR has the potential to fundamentally change the surgical experience by giving the surgeon a new dimension of information in an easy-to-use way,” said Simon Karger, head of surgical and interventional products at Cambridge Consultants. “While today’s platforms still need to mature before they are ready for clinical deployment, it is clear to us that the underlying technology holds great promise for critical applications like surgery.

Currently, surgeons have limited access to real-time imaging while they perform procedures. The AR system also allows surgeons to view patient records and operating information.

“This innovative development is the result of our extensive experience of surgical equipment innovation and our understanding of the operating theatre environment and workflow,” said Karger. “It has the potential to enable more surgeons to carry out complex operations at lower risk and with better results for patients.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.